Extending the benefit ef lipid-reguulating therapy to primary prevention

The American Journal of Cardiology

Volumn 76, Issue 9 SUPPL. 1, 1995, Pages 118C-121C

  Jones, Peter H ^a   Gotto Jr , Antonio M ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ESTROGEN; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; PROGESTERONE;

ANTIHYPERTENSIVE THERAPY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY RISK; DIET THERAPY; ESTROGEN THERAPY; HUMAN; MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL;

AGED; ANTICHOLESTEREMIC AGENTS; CORONARY DISEASE; FEMALE; HUMAN; LIPIDS; LIPOPROTEINS, HDL CHOLESTEROL; LIPOPROTEINS, LDL CHOLESTEROL; LOVASTATIN; MALE; MIDDLE AGE; PRAVASTATIN; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS;

EID: 0029130093     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)80481-0     Document Type: Article

References (17)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
2. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease
3. Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
4. The Lipid Research Clinics Coronary Primary Prevention Trial Results
5. The west of Scotland Coronary Prevention study: A trial of cholesterol reduction in scottish men
6. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men
7. Cholesterol and lipids in the risk of coronary artery disease: the Framingham Heart Study
8. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implication for treatment
9. Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women
10. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
11. Largest US clinical trial ever gets under way
12. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
13. Serum cholesterol. Doing the right thing
14. Cholesterol and total mortality: need for larger trials (Letter.)
15. Prospective meta-analysis of cholesterol-lowering studies: The prospective pravastatin pooling (PPP) project and the cholesterol treatment trialists (CTT) collaboration
16. Prevalence of high blood cholesterol among US adults. An update based on guidelines from the Second Report of the National Cholesterol Education Program Adult Treatment Panel